Cardio Diagnostics Holdings Presents Precision Cardiovascular Solutions for Employers and Health Plans

Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence, presented its innovative approaches to cardiovascular disease prevention, risk assessment, and cost management at multiple national benefits conferences this month. The company highlighted how advanced cardiovascular risk assessment and detection tools can support both improved health outcomes and more effective healthcare cost management.

According to a recent article, the company's message centers on the idea that earlier identification of cardiovascular risk and disease can potentially enable more targeted interventions and preventive care. Rather than waiting until symptoms develop or major events occur, employers and health plans may benefit from tools that help identify elevated risk or silent disease before they progress. This preventive focus aligns with broader trends in healthcare, where organizations are increasingly emphasizing population health management and proactive risk reduction.

Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence-driven Integrated Genetic-Epigenetic Engine for cardiovascular disease.

For more details, the full article is available at https://ibn.fm/6swfk. The latest news and updates relating to CDIO can be found in the company's newsroom at https://ibn.fm/CDIO.

Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties, including those set forth under the heading "Risk Factors" in the Company's most recent Annual Report on Form 10-K and other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article.